![Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities | Molecular Pharmaceutics Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c01080/asset/images/large/mp2c01080_0002.jpeg)
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities | Molecular Pharmaceutics
![Vittorio Manzari's research works | University of Rome Tor Vergata, Rome (UNIROMA2) and other places Vittorio Manzari's research works | University of Rome Tor Vergata, Rome (UNIROMA2) and other places](https://www.researchgate.net/publication/361540770/figure/fig1/AS:11431281097186357@1668483200546/Effect-of-GANT-61-GANT-and-Afatinib-AFA-alone-or-in-combination-on-MM-cell-lines_Q320.jpg)
Vittorio Manzari's research works | University of Rome Tor Vergata, Rome (UNIROMA2) and other places
![Moreno MENEGHETTI | University of Padova, Padova | UNIPD | Department of Chemical Sciences | Research profile Moreno MENEGHETTI | University of Padova, Padova | UNIPD | Department of Chemical Sciences | Research profile](https://i1.rgstatic.net/ii/profile.image/272766414880793-1442043989640_Q512/Moreno-Meneghetti.jpg)
Moreno MENEGHETTI | University of Padova, Padova | UNIPD | Department of Chemical Sciences | Research profile
![Ludmil TSANKOV | Doctor of Philosophy | Sofia University "St. Kliment Ohridski", Sofia | Department of Nuclear Engineering | Research profile Ludmil TSANKOV | Doctor of Philosophy | Sofia University "St. Kliment Ohridski", Sofia | Department of Nuclear Engineering | Research profile](https://i1.rgstatic.net/ii/profile.image/395663281016849-1471344885818_Q512/Ludmil-Tsankov.jpg)
Ludmil TSANKOV | Doctor of Philosophy | Sofia University "St. Kliment Ohridski", Sofia | Department of Nuclear Engineering | Research profile
![Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities | Molecular Pharmaceutics Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c01080/asset/images/large/mp2c01080_0001.jpeg)